Fortress Biotech (FBIO) Divestments (2019 - 2025)
Fortress Biotech (FBIO) posted quarterly Divestments of $2.9 million for Q3 2025, down 88.57% quarter-over-quarter from $25.1 million in Q2 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Divestments (2019 - 2025) Analysis & Trends
Fortress Biotech's Divestments history runs 2 years deep, the most recent figure standing at $2.9 million for Q3 2025.
- In Q3 2025, Divestments changed N/A year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $28.0 million (changed N/A YoY), while the FY2025 annual figure was $9.0 million, changed N/A from the prior year.
- Divestments for Q3 2025 stood at $2.9 million, down from $25.1 million in the prior quarter.
- The five-year high for Divestments was $25.1 million in Q2 2025, with the low at $2.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 25.10 Mn |
| Mar 31, 2019 | 13.09 Mn |